US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Ageas SA NV (FO4N) 銘柄情報

Ageas SA NV (FO4N)

66.80

-0.10

(-0.15%)

終了 6月13日 5:00AM

Ageas SA NV (FO4N) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

66.80

( -0.15% )

買値

66.65

売値

66.95

出来高

308

66.30 日の範囲 66.65

55.05 52 週間の範囲 69.35

時価総額

前日終値

66.90

始値

66.60

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

345,112 €

発行済株式数

190,727,000

配当利回り

3.75 (5.58%)

PER

6.99

1 株当たり利益 (EPS)

9.09

歳入

9.43B

純利益

1.71B

ageas SA/NV, together with its subsidiaries, engages in insurance business. It operates through five segments: Belgium, Europe, Asia, Reinsurance, and General Account. The company provides property, casualty, and life insurance products, as well as pension products; and reinsurance products. It offe... ageas SA/NV, together with its subsidiaries, engages in insurance business. It operates through five segments: Belgium, Europe, Asia, Reinsurance, and General Account. The company provides property, casualty, and life insurance products, as well as pension products; and reinsurance products. It offers life insurance products include risks related to the life, and death of individuals; and non-life insurance products comprise accident and health, motor, and fire insurance products, as well as insurance services for other damages to property; and pension funds. The company serves private individuals, as well as small, medium-sized, and large companies through independent brokers and the bank channels. ageas SA/NV was founded in 1824 and is based in Brussels, Belgium. 詳細を表示

セクター

Finance

業界

Insurance

ウェブサイト

www.ageas.com

本社

Brussels, Belgium

設立

2026

Ageas SA NV is listed in the Finance sector of the Tradegate (DE) with ticker FO4N. The last closing price for Ageas SA NV was 66.90 €. Over the last year, Ageas SA NV shares have traded in a share price range of 55.05 € to 69.35 €.

Ageas SA NV currently has 190,727,000 shares in issue. The market capitalisation of Ageas SA NV is 12.74 € billion. Ageas SA NV has a price to earnings ratio (PE ratio) of 6.99.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	3.5	5.52922590837	63.3	66.75	62.8	670	64.50978806	DE
4	-0.95	-1.40221402214	67.75	69.349999	62.8	684	66.31929639	DE
12	6	9.86842105263	60.8	69.349999	57.7	862	65.88038826	DE
26	9.1	15.7712305026	57.7	69.349999	57.5	987	62.61784528	DE
52	9.95	17.5021987687	56.85	69.349999	55.05	886	60.63706217	DE
156	29.05	76.9536423841	37.75	69.349999	35.67	835	49.98062478	DE
260	20.3	43.6559139785	46.5	69.349999	34.1	642	49.37173469	DE

FO4N - Frequently Asked Questions (FAQ)

What is the current Ageas SA NV share price?

The current share price of Ageas SA NV is 66.80 €

How many Ageas SA NV shares are in issue?

Ageas SA NV has 190,727,000 shares in issue

What is the market cap of Ageas SA NV?

The market capitalisation of Ageas SA NV is EUR 12.74B

What is the 1 year trading range for Ageas SA NV share price?

Ageas SA NV has traded in the range of 55.05 € to 69.35 € during the past year

What is the PE ratio of Ageas SA NV?

The price to earnings ratio of Ageas SA NV is 6.99

What is the cash to sales ratio of Ageas SA NV?

The cash to sales ratio of Ageas SA NV is 1.28

What is the registered address of Ageas SA NV?

The registered address for Ageas SA NV is Manhattan Center, Brussels, Brussels, 1210

What is the Ageas SA NV website address?

The website address for Ageas SA NV is www.ageas.com

Which industry sector does Ageas SA NV operate in?

Ageas SA NV operates in the Insurance sector

Talisman33

Talisman33 7分前

Ask Amazon? More like ask why they don't sell Lunar on Amazon. Did something happen when they tried selling Acute/Defense with them?

SovereignNinja5

SovereignNinja5 14分前

LMAO ok Beer, I know where you get your info. Send my regards. PBM decisions are not what you think.
This is cute.
“Amarin's benefit from the science will come from Europe and ROW, and Guideline upgrades in those regions.”

The OUS Revenue Reality Check
Looking a

iHub News

iHub News 16分前

BofA’s Hartnett Warns Bullish Positioning Remains Entrenched Despite 5% Bond YieldsJune 13, 2026 7:00 AM
IH Market News

iHub News

iHub News 16分前

BofA’s Hartnett Warns Bullish Positioning Remains Entrenched Despite 5% Bond YieldsJune 13, 2026 7:00 AM
IH Market News

Implanting

Implanting 18分前

There's a lot of uncertainty around how this negotiations process with the First Nations even works. Unless you're in the mine start-up business, it's a long, sorted process between the potential miner, government agencies, and the Natives. These community votes may be in most part "window dressing"

brazen22

brazen22 21分前

Doc, the issue is not whether the SAP included bias checks. Of course it did. The issue is whether those checks were sufficient to prove the external control population was comparable enough to support treatment effect.

Bias checks can reduce concern, but they do not create randomizat

FooBarAndGrill

FooBarAndGrill 21分前

Yes. Quite entertaining.
https://www.linkedin.com/feed/update/urn:li:activity:7470142453950447616/

ITYS

Yes, yes ...we all know what the bid and ask are.
You’re explaining mechanics like that’s the issue here, when the real problem is you’re trying to apply big-float logic to a 9.7M float. That’s why your whole “we need volume every day” argument falls apart.

You keep talking lik

nicehit

nicehit 27分前

Umm, they say Quantum was 20 years away. It's here today. Fusion is coming, and both (Fusion/Nuclear) will co-exist!

yielddude

yielddude 31分前

Congrats SteveSchiets! And to Nsom as well. And thanks again to Sskillz1 for running these contests.

gerry57

gerry57 32分前

I recognize your name from another board . Let’s hope this ceo is far more competent and trustworthy, this moa while different tries to accomplish the same sort of endgame, a neuron closer to homeostasis .

US Market News

US Market News 46分前

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myelomaJune 13, 2026 6:33 AM
PR Newswire (US)

band aid

band aid 47分前

She said after the New Year we would learn more. Got to cut her some slack LOL it's only mid June. Maybe she meant Christmas in July. Anyway you look at it it's a new start up company that takes a lil time to raise capital to buy relish for the hotdog stand.

Investor082

Investor082 52分前

Gary, Eden won’t be certified for commercial production until 2028 at the earliest. That too is highly uncertain and unlikely given NWBO’s history. In fact, its more likely they abandon the project or find some excuse to stall in 2027 than a commercial certification of Eden in 2028.

W

TRAPPER JIM

TRAPPER JIM 55分前

I got all the ceilings downstairs painted except for the kitchen and the bathroom last night. So the only ceilings I have left to paint now are the kitchen, bathroom, one closet and the laundry room. And I’m not sure about the garage ceiling. I need to look at it today. Just thought about that one.

Investor082

Investor082 57分前

“No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA approval for years or until they complete additional trials.”

- I agree with that. This is why no institutiona

US Market News

US Market News 1時間前

Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United StatesJune 13, 2026 6:22 AM
Business Wire Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together refer

StockItOut

StockItOut 1時間前

Now how do you know that?

“BOXABL has actually been in contact with XERI.”

.

Investor082

Investor082 1時間前

LOL, no excuses when Flaskworks is not certified for commercial production this year and then again next year, OK?

Anything else is just fluff at this point. It will again prove they are desperate to PR anything and that more importantly UK decision is many months away.

cottonisking

cottonisking 1時間前

Lehman Brothers and Reality (Class 10B payday ?): 14 sites Reality is the totality of all things that exist, independent of whether we are aware of them, believe in them, or understand them. While that definition sounds simple, how reality actually operates depends entirely on the lens—scientific, p

Ranb2khz

Ranb2khz 1時間前

Pentagon releases third batch of UFO files, including civilian videos

~ by www.christianpost.com/by/cp-staff CP Staff , June 13, 2026
____________

The Pentagon released its third batch of files related to unidentified anomalous phenomena (UAPs) or UFOs on Frida

SCAMBUSTERKING

SCAMBUSTERKING 1時間前

You are the only shareholder, this board exists solely to ensure no more shareholders are created.

US Market News

US Market News 2時間前

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free SurvivalJune 13, 2026 6:00 AM
Business Wire - f

Ranb2khz

Ranb2khz 2時間前

In Other News: Google Security Layoffs, AudiA6 Takedown, $400 Million Coupang Fine

~ Other noteworthy stories that might have slipped under the radar: ICS device exposure remains flat as attack surface widens, Microsoft issues incident response playbook for AI, IBM and AT&T accused of

Genius Products (EM)

Charge Enterprises

Andrew Peller (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。